Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myofibroblastic conversion of mesothelial cells.

An Hang Yang1, Jinn Yang Chen, Jen Kou Lin

  • 1Department of Pathology, Taipei Veterans General Hospital and School of Medicine, National Yang-Ming University, Taipei, Taiwan. ahyang@vghtpe.gov.tw

Kidney International
|March 13, 2003
PubMed
Summary

Transforming growth factor-beta 1 (TGF-beta 1) induces human peritoneal mesothelial cells (HPMC) to transdifferentiate into myofibroblasts, contributing to peritoneal fibrosis during dialysis. This study elucidates the cellular and molecular mechanisms involved.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of botulinum toxin A on the contractile function of dog prostate.

European urology·2007
Same author

Expression of adhesion molecules and Ki-67 in female adnexal tumor of probable Wolffian origin (FATWO): report of two cases and review of the literature.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2004
Same author

The dysregulated glomerular cell growth in Denys-Drash syndrome.

Virchows Archiv : an international journal of pathology·2004
See all related articles

Area of Science:

  • Cell biology
  • Renal medicine
  • Pathology

Background:

  • Continuous ambulatory peritoneal dialysis (CAPD) can cause peritoneal fibrosis due to continuous insults.
  • Transforming growth factor-beta 1 (TGF-beta 1) is implicated in fibrotic processes, but its role in peritoneal fibrosis is not fully understood.

Purpose of the Study:

  • To investigate the effects of exogenous TGF-beta 1 on human peritoneal mesothelial cells (HPMC).
  • To elucidate the mechanisms of TGF-beta 1-induced peritoneal fibrosis.

Main Methods:

  • Assessed cytoarchitectural changes in HPMC using various microscopy techniques.
  • Analyzed differential gene expression via RT-PCR and cDNA expression arrays.

Main Results:

Related Experiment Videos

  • TGF-beta 1 induced HPMC transdifferentiation into myofibroblasts, characterized by specific cellular structures and extracellular matrix deposition.
  • Gene expression analysis revealed significant modulation in pathways related to cytoskeleton, cell adhesion, ECM production, and immune response.

    • Conclusions:

    • Myofibroblastic conversion of mesothelial cells is a key process in peritoneal fibrosis.
    • This transdifferentiation contributes to fibrotic cell recruitment during serosal inflammation and wound healing.